Research Article
Mortality among Cancer Patients within 90 Days of Therapy in a Tertiary Hospital, Tanzania: Is Our Pretherapy Screening Effective?
Table 3
Factors associated with mortality within 90 days of therapy.
| | Variable | Dead (12) | Alive (90) | value | | Number (%) median [IQR] | Number (%) median [IQR] |
| | HIV status | | | | | Unknown (21) | 3 (14.3) | 18 (85.7) | | Negative (62) | 9 (14.5) | 53 (85.5) | | Positive (19) | 0 (0) | 19 (100) | 0.211 | | Baseline body temperature (°C) | 36.2 [35.4-36.4] | 36.2 [35.7-36.7] | 0.4023 | | BMI | 23.8 [21.7-25] | 22.9 [20.2-25.9] | 0.453 | | Cancer type | | | | | Others (90) | 8 (8.9) | 82 (91.1) | | | Head and neck (12) | 4 (33.3) | 8 (66.67) | 0.014 | | Therapy type | | Cisplatin (50) | 7 (14.0) | 43 (86.0) | 0.492 | | 5-Fluorouracil (10) | 4 (40.0) | 6 (60.0) | 0.004 | | Paclitaxel (22) | 1 (4.5) | 21 (95.5) | 0.235 | | Carboplatin (9) | 2 (22.2) | 7 (77.8) | 0.308 | | Dacarbazine (4) | 1 (25.0) | 3 (75) | 0.402 | | Docetaxel (6) | 2 (33.3) | 4 (66.7) | 0.091 | | Karnofsky score (%) | 80 [70-85] | 90 [80-90] | 0.001 | | Baseline Hb (g/dL) | 10 [9.3-10.8] | 11.8 [10.5-12.7] | 0.001 | | Baseline white blood cell (×109/L) | 4.9 [4.4-5.7] | 5.2 [4-6.7] | 0.226 | | Baseline neutrophil (×109/L) | 3.1 [2.6-4.6] | 3 [2-4.1] | 0.653 | | Body temperature visit (°C) | | Visit 1 | 36.6 [36.1-37] | 36.4 [35.9-36.8] | 0.852 | | Visit 2 | 36.7 [36-36.9] | 36.2 [35.8-36.8] | 0.677 | | Visit 3 | 36.1 [36.1-36.3] | 36.3 [35.8-36.8] | 0.565 | | Visit 4 | 36.3 [35.5-37.1] | 36.2 [35.7-36.6] | 0.758 | | Visit 5 | 35.2 [35.2-35.2] | 36.4 [35.9-37] | 0.490 |
|
|
